ensitrelvir
Ensitrelvir Can Prevent COVID-19 Transmission in Households
Ensitrelvir (Shionogi) administered within 72 hours of household COVID-19 exposure reduced the number of people ...
JULY 16, 2025
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 3, 2025
Ensitrelvir PEP Continues to Prevent SARS-CoV-2 Infection
If given within 72 hours after clinical onset of COVID-19 in a household, oral ensitrelvir was effective in ...
APRIL 14, 2025
Ensitrelvir Reduced the Risk for COVID-19 by 67%
Ensitrelvir, an antiretroviral being developed to prevent COVID-19, reduced the risk of developing the infection by ...
MARCH 12, 2025
Novel Ensitrelvir Provides Early Resolution of Many Common COVID-19 Symptoms
The novel COVID-19 treatment, ensitrelvir, shows both clinical symptom improvement and an antiviral effect in a ...
MARCH 1, 2024
